THE CALMER CO INTERNATIONAL ORD
FDA Greenlights Kava as Food, Boosting Calmer Co's US Expansion
The Calmer Co (ASX: CCO) has secured significant regulatory clarity from the US FDA, which confirmed traditionally prepared kava beverages as food products, de-risking its US expansion and dual-catego
The Calmer Co International Closes Second Tranche of $1.4 Million Convertible Note Raise
The Calmer Co International (ASX: CCO) has closed the second tranche of its previously announced secured convertible note raise, completing the planned $1.4 million funding round.
The Calmer Co Announces Chair Transition Ahead of Accelerated US Expansion
The Calmer Co International (ASX: CCO) has announced the appointment of veteran beverage executive James S. Tonkin as its new chair, following the resignation of John Homewood on the first anniversary of his appointment.
The Calmer Co Moves Closer to Profitability with Record Quarterly Revenue and Strong Sales Growth
The Calmer Co (ASX: CCO) has reported record global revenue of $2.4 million for the September 2026 quarter, a 26% increase on the previous quarter as strong sales growth across Australia and the US drove the company closer to breakeven. The company said the result reflected accelerating momentum in both retail and wholesale markets, supported by […]